AUGMENTIN 875 MG TABLETS

Страна: Ізраїль

мова: англійська

Джерело: Ministry of Health

Активний інгредієнт:

AMOXICILLIN AS TRIHYDRATE; CLAVULANIC ACID AS POTASSIUM SALT

Доступна з:

GLAXO SMITH KLINE (ISRAEL) LTD

Код атс:

J01CR01

Фармацевтична форма:

FILM COATED TABLETS

Склад:

AMOXICILLIN AS TRIHYDRATE 875 MG; CLAVULANIC ACID AS POTASSIUM SALT 125 MG

Адміністрація маршрут:

PER OS

Тип рецепту:

Required

Виробник:

SMITHKLINE BEECHAM PHARMACEUTICALS, UK

Терапевтична група:

AMPICILLIN AND ENZYME INHIBITOR

Терапевтична области:

AMPICILLIN AND ENZYME INHIBITOR

Терапевтичні свідчення:

Augmentin is indicated for the treatment of the following infections in adults and children :• Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.

Дата Авторизація:

2012-09-30

інформаційний буклет

62000000047669
GSK_MAYENNE_FRANCE
PAGE 1 OF 1
Project: CO-0028544
Site Code: 62000000047669
Document: PPC-3300328
Version: 2
Operator: SRM58890
Date/Time Created: 03.Feb.2020 13:46 GMT
e-Banner

Характеристики продукта

Page
1
of
15
Augmentin 500 mg Tablets
SUMMARY OF PRODUCT CHARACTERISTICS
Augmentin 500 mg Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains amoxicillin trihydrate equivalent to
500 mg amoxicillin and
potassium clavulanate equivalent to 125 mg of clavulanic acid.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet.
White to off-white, oval film-coated tablets debossed with ‘AC’
and a score line on one side.
The score line is only to facilitate breaking for ease of swallowing
and not to divide into equal doses.
4.
CLINICAL PARTICULARS
4.1
Therapeutic indications
Augmentin is indicated for the treatment of the following infections
in adults and children (see
sections 4.2, 4.4 and 5.1):
•
Acute bacterial sinusitis (adequately diagnosed)
•
Acute otitis media
•
Acute exacerbations of chronic bronchitis (adequately diagnosed)
•
Community acquired pneumonia
•
Cystitis
•
Pyelonephritis
•
Skin and soft tissue infections in particular cellulitis, animal
bites, severe dental abscess with
spreading cellulitis
•
Bone and joint infections, in particular osteomyelitis.
Consideration should be given to official guidance on the appropriate
use of antibacterial agents.
4.2
Posology and method of administration
Posology
Doses are expressed throughout in terms of amoxicillin/clavulanic acid
content except when doses are
stated in terms of an individual component.
The dose of Augmentin that is selected to treat an individual
infection should take into account:
•
The expected pathogens and their likely susceptibility to
antibacterial agents (see section 4.4)
Page
2
of
15
•
The severity and the site of the infection
•
The age, weight and renal function of the patient as shown below.
The use of alternative presentations of Augmentin (e.g. those that
provide higher doses of amoxicillin
and/or different ratios of amoxicillin to clavulanic acid) should be
considered as necessary (see sections
4.4 and 5.1).
For adults and children
≥
40 kg,